Skip Navigation


Schizophrenia Bulletin Advance Access originally published online on October 5, 2007
Schizophrenia Bulletin 2007 33(6):1274-1276; doi:10.1093/schbul/sbm101
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
33/6/1274    most recent
sbm101v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Jayaram, M. B.
Right arrow Articles by Stroup, T. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jayaram, M. B.
Right arrow Articles by Stroup, T. S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org.

Risperidone Versus Olanzapine for Treatment of Schizophrenia

Mahesh B. Jayaram1,2, Prakash M. Hosalli3 and Thomas S. Stroup4
2 Leeds Mental Health Trust, Bridge House, Balm Road, Leeds LS10 2TP, UK
3 Leeds Mental Health Trust, Newsam Centre, Seacroft, Leeds LS14 6WB, UK
4 Department of Psychiatry, University of North Carolina at Chapel Hill, CB# 7160, Chapel Hill, NC 27599-7160

Keywords: risperidone / olanzapine / schizophrenia / systematic review / meta-analysis

The first 10% of the full text of this article appears below.


   Background
 
Antipsychotic medication is a mainstay of treatment for schizophrenia. Risperidone and olanzapine are popular choices among the new generation drugs.


   Objectives
 
To determine the clinical effects, safety and cost effectiveness of risperidone were compared with those of olanzapine for treating schizophrenia.


   Search Strategy
 
We searched the Cochrane Schizophrenia Group's Register (September 2005), and references of all identified studies were inspected for further trials. We also contacted relevant pharmaceutical . . . [Full Text of this Article]


   Selection Criteria
 

   Data Collection and Analysis
 

   Main Results
 

   Conclusions
 
1 To whom correspondence should be addressed; tel: +44-113-3058302, fax: +44-113-277-2830, e-mail: maheshbj@gmail.com.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?